CLARK IAN T (CIK 1336504) reported 27 SEC Form 4 insider transactions across 5 companies over the past 18 months (most recent 2026-08-05). Recent activity: Buy GH (2,255 shares), Buy GH (6,833 shares), Sell GH (9,088 shares), Sell GH (5,092 shares), Buy GH (5,092 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Guardant Health, Inc. (GH) | Director | Buy | 2,255 | $205,453 |
| 2026-08-05 | Guardant Health, Inc. (GH) | Director | Buy | 6,833 | $345,545 |
| 2026-08-05 | Guardant Health, Inc. (GH) | Director | Sell | 9,088 | $1.4M |
| 2026-08-05 | Guardant Health, Inc. (GH) | Director | Sell | 5,092 | $808,626 |
| 2026-06-22 | Guardant Health, Inc. (GH) | Director | Buy | 5,092 | $0 |
| 2026-06-04 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Director | Buy | 7,490 | $0 |
| 2026-05-29 | Kyverna Therapeutics, Inc. (KYTX) | Director | Buy | 5,093 | $0 |
| 2026-05-22 | Guardant Health, Inc. (GH) | Director | Sell | 6,876 | $735,049 |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 29,904 | $862,132 |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Buy | 21,520 | $77,687 |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Buy | 21,520 | $168,717 |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Buy | 12,070 | $49,246 |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Buy | 209,690 | $924,733 |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 193,056 | $5.7M |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 41,840 | $1.3M |
| 2025-12-08 | Guardant Health, Inc. (GH) | Director | Buy | 9,105 | $349,814 |
| 2025-12-08 | Guardant Health, Inc. (GH) | Director | Buy | 8,803 | $334,602 |
| 2025-12-08 | Guardant Health, Inc. (GH) | Director | Buy | 10,703 | $340,784 |
| 2025-12-08 | Guardant Health, Inc. (GH) | Director | Sell | 8,156 | $870,001 |
| 2025-12-08 | Guardant Health, Inc. (GH) | Director | Sell | 17,055 | $1.8M |
| 2025-12-08 | Guardant Health, Inc. (GH) | Director | Sell | 3,400 | $367,370 |
| 2025-08-05 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Director | Buy | 7,000 | $0 |
| 2025-07-09 | GoodRx Holdings, Inc. (GDRX) | Director | Buy | 17,248 | $81,756 |
| 2025-06-20 | Guardant Health, Inc. (GH) | Director | Sell | 6,672 | $322,791 |
| 2025-06-16 | Guardant Health, Inc. (GH) | Director | Buy | 8,088 | $0 |
Source: SEC Form 4 filings · as of 2026-08-05